In one paragraphArticle in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
16 authors.
Pasquale SibilioDepartment of Computer, Control and Management Engineering, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0001-8477-9020 Ilaria Grazia ZizzariLaboratory of Tumor Immunology and Cell Therapies, Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0001-8263-7248 Alain GelibterDivision of Oncology, Department of Radiological, Oncological and Pathological Science, Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, Italy.
Marco SiringoDivision of Oncology, Department of Radiological, Oncological and Pathological Science, Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0002-0489-1790 Lucrezia TuostoLaboratory of Tumor Immunology and Cell Therapies, Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Angelica PaceLaboratory of Tumor Immunology and Cell Therapies, Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0003-2097-7874 Angela AsquinoLaboratory of Tumor Immunology and Cell Therapies, Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Flavio ValentinoLaboratory of Tumor Immunology and Cell Therapies, Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Arianna SabatiniDivision of Oncology, Department of Radiological, Oncological and Pathological Science, Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0009-0008-1769-5693 Manuela PettiDepartment of Computer, Control and Management Engineering, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0002-0149-161X Filippo BellatiDepartment of Medical and Surgical Sciences and Translational Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, Via di Grottarossa 1035, 00189 Rome, Italy.
Daniele SantiniDivision of Oncology, Department of Radiological, Oncological and Pathological Science, Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, Italy.
Marianna NutiLaboratory of Tumor Immunology and Cell Therapies, Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0003-1809-1003 Lorenzo FarinaDepartment of Computer, Control and Management Engineering, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0001-8314-6029 Aurelia RughettiLaboratory of Tumor Immunology and Cell Therapies, Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0002-1863-8251 Chiara NapoletanoLaboratory of Tumor Immunology and Cell Therapies, Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0001-5449-5430 Funding
Ministero dell'università e della ricerca 2022K5RYF5Sapienza University of Rome RM120172B40A805ASapienza University of Rome RM12117A7B767D0DSapienza University of Rome RM12117A85361029Sapienza University of Rome RM1221816BC0EAASapienza University of Rome RM123188C3F3E706Sapienza University of Rome RP122181610A7266
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
anti-PD1 therapynetwork analysisNSCLC
Identifiers
PMID40149259
PMCPMC11939851
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390